Circulating irisin is associated with osteoporotic fractures in postmenopausal women with low bone mass but is not affected by either teriparatide or denosumab treatment for 3 months

被引：0
|
作者：
A. D. Anastasilakis
S. A. Polyzos
P. Makras
A. Gkiomisi
I. Bisbinas
A. Katsarou
A. Filippaios
C. S. Mantzoros
机构：
[1] 424 General Military Hospital,Department of Endocrinology
[2] Aristotle University of Thessaloniki,Department of Medicine, Second Medical Clinic, Ippokration General Hospital
[3] 251 Hellenic Air Force & VA General Hospital,Department of Endocrinology and Diabetes
[4] 424 General Military Hospital,Department of Obstetrics and Gynaecology
[5] 424 General Military Hospital,2nd Department of Orthopaedics
[6] Hellenic Military School of Medicine,Department of Internal Medicine, Division of Endocrinology, Diabetes and Metabolism, Beth Israel Deaconess Medical Center
[7] Harvard Medical School,undefined
来源：
Osteoporosis International | 2014年 / 25卷
关键词：
Bone metabolism; Denosumab; Fracture; Irisin; Osteoporosis; Teriparatide;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1633 / 1642
页数：9
相关论文
共 50 条
  • [1] Circulating irisin is associated with osteoporotic fractures in postmenopausal women with low bone mass but is not affected by either teriparatide or denosumab treatment for 3 months
    Anastasilakis, A. D.
    Polyzos, S. A.
    Makras, P.
    Gkiomisi, A.
    Bisbinas, I.
    Katsarou, A.
    Filippaios, A.
    Mantzoros, C. S.
    OSTEOPOROSIS INTERNATIONAL, 2014, 25 (05) : 1633 - 1642
  • [2] Circulating noggin levels following treatment with denosumab or teriparatide in postmenopausal women with low bone mass
    Anastasilakis, Athanasios D.
    Polyzos, Stergios A.
    Makras, Polyzois
    Rauner, Martina
    Sonnleitner, Linda
    Hawa, Gerhard
    Tsourdi, Elena
    Yavropoulou, Maria P.
    Missbichler, Albert
    Terpos, Evangelos
    JOURNAL OF MUSCULOSKELETAL & NEURONAL INTERACTIONS, 2019, 19 (03) : 253 - 257
  • [3] Efficacy of 4-year denosumab treatment alone or in combination with teriparatide in Japanese postmenopausal osteoporotic women
    Suzuki, Takako
    Nakamura, Yukio
    Kato, Hiroyuki
    MODERN RHEUMATOLOGY, 2019, 29 (04) : 676 - 681
  • [4] Circulating semaphorin-4D and plexin-B1 levels in postmenopausal women with low bone mass: the 3-month effect of zoledronic acid, denosumab or teriparatide treatment
    Anastasilakis, Athanasios D.
    Polyzos, Stergios A.
    Makras, Polyzois
    Gkiomisi, Athina
    Sakellariou, Grigorios
    Savvidis, Matthaios
    Papatheodorou, Athanasios
    Kokkoris, Panagiotis
    Terpos, Evangelos
    EXPERT OPINION ON THERAPEUTIC TARGETS, 2015, 19 (03) : 299 - 306
  • [5] Denosumab for the Treatment of Postmenopausal Women at Increased Risk of Osteoporotic Fractures
    Bogado, Cesar E.
    CLINICAL MEDICINE INSIGHTS-THERAPEUTICS, 2011, 3 : 395 - 402
  • [6] Denosumab effects on bone density and turnover in postmenopausal women with low bone mass with or without previous treatment
    Tsourdi, Elena
    Makras, Polyzois
    Rachner, Tilman D.
    Polyzos, Stergios
    Rauner, Martina
    Mandanas, Stylianos
    Hofbauer, Lorenz C.
    Anastasilakis, Athanasios D.
    BONE, 2019, 120 : 44 - 49
  • [7] Trabecular bone microarchitecture predicts fragility fractures in postmenopausal women on denosumab treatment
    Butscheidt, Sebastian
    Rolvien, Tim
    Vettorazzi, Eik
    Frieling, Isolde
    BONE, 2018, 114 : 246 - 251
  • [8] Effects of Denosumab Treatment and Discontinuation on Bone Mineral Density and Bone Turnover Markers in Postmenopausal Women with Low Bone Mass
    Bone, Henry G.
    Bolognese, Michael A.
    Yuen, Chui Kin
    Kendler, David L.
    Miller, Paul D.
    Yang, Yu-Ching
    Grazette, Luanda
    San Martin, Javier
    Gallagher, J. Christopher
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2011, 96 (04) : 972 - 980
  • [9] TREATMENT WITH TERIPARATIDE MIGHT BE ASSOCIATED WITH CARDIOMETABOLIC CHANGES IN POSTMENOPAUSAL SEVERE OSTEOPOROTIC WOMEN
    Passeri, E.
    Dozio, E.
    Mendola, M.
    Costa, E.
    Bandera, F.
    Romanelli, M. M. Corsi
    Corbetta, S.
    JOURNAL OF BIOLOGICAL REGULATORS AND HOMEOSTATIC AGENTS, 2015, 29 (04) : 931 - 940
  • [10] Effects of Romosozumab Compared With Teriparatide on Bone Density and Mass at the Spine and Hip in Postmenopausal Women With Low Bone Mass
    Genant, Harry K.
    Engelke, Klaus
    Bolognese, Michael A.
    Mautalen, Carlos
    Brown, Jacques P.
    Recknor, Chris
    Goemaere, Stefan
    Fuerst, Thomas
    Yang, Yu-Ching
    Grauer, Andreas
    Libanati, Cesar
    JOURNAL OF BONE AND MINERAL RESEARCH, 2017, 32 (01) : 181 - 187
12345